Lumos Diagnostics receives FDA EUA for ViraDx Rapid POC Test
Lumos Diagnostics (ASX: LDX) has announced that its ViraDx test has been granted Emergency Use Authorization (EUA) and a CLIA Waiver by the US Food ... Read More
Lumos Diagnostics, Henry Schein sign distribution deal for FebriDx Test in Iberia
Lumos Diagnostics (ASX: LDX), a leading name in rapid, point-of-care diagnostic technologies, has entered into a distribution agreement with Henry Schein Medical, S.L.U., for its ... Read More